ArticleIndian journal of dermatology
Clinical Profile of Neurofibromatosis Type 1: Paediatric Patients from a Tertiary Care Centre.
Article in Indian journal of dermatology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Neurofibromatosis Type 1 (NF1) is a genetic disorder involving multiple organ systems, primarily the nervous system and skin. It presents with diverse cutaneous, neurological, and systemic manifestations, many of which appear early in life (under 5 years of age). Early recognition of its clinical features is crucial for timely, multidisciplinary management. There is limited data on the clinical profile of paediatric NF1 in India. This case series describes the clinical characteristics of children diagnosed with NF1 in a tertiary care centre. The aim was to describe the clinical and systemic features of paediatric NF1 in the Indian population. Objectives included identifying early cutaneous signs, evaluating systemic involvement, assessing family history patterns, and emphasising the need for early diagnosis and coordinated care. The study was conducted at the paediatric dermatology outpatient department of a tertiary care hospital in Delhi. Records from a dedicated genodermatosis clinic were reviewed. Children fulfilling the NIH diagnostic criteria for NF1 were included. Clinical features, imaging findings, and systemic associations were extracted and analysed. Among 25 children diagnosed with NF1, 15 were females and 10 were males, with age at diagnosis ranging from 2 to 18 years. A positive family history was noted in 52% of cases. Café-au-lait macules (CALMs) were seen in all patients; 80% had them at birth. Neurofibromas were observed in 64%, including plexiform neurofibromas in 8%. Intertriginous freckling and Lisch nodules were each noted in 52% of cases. Developmental delay was seen in 24%, with gross motor and speech delays. Scoliosis was identified in 12%. No oral or cardiovascular abnormalities were found. This study highlights the importance of early dermatological and systemic screening in children with NF1. Timely recognition of clinical signs is essential for effective multidisciplinary management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.